Skip to main content
Zydus Lifesciences Limited logo

Zydus Lifesciences Limited — Investor Relations & Filings

Ticker · ZYDUSLIFE ISIN · INE010B01027 LEI · 335800R9O14ORBXLPN13 BSE.NS Manufacturing
Open in API
Filings indexed 1,808 across all filing types
Latest filing 2026-05-24 Call Transcript
Country IN India
Listing BSE.NS ZYDUSLIFE

About Zydus Lifesciences Limited

https://zyduslife.com/

Zydus Lifesciences Limited is a research-driven global organization focused on the discovery, development, and commercialization of diverse healthcare solutions. Its extensive portfolio encompasses generic formulations, specialty drugs, biosimilars, vaccines, and active pharmaceutical ingredients. The company maintains a strong focus on therapeutic areas including oncology, cardiology, respiratory, dermatology, and metabolic disorders. Notable innovations include the development of Saroglitazar, a first-in-class treatment for NASH, and pioneering work in DNA vaccine technology. By leveraging advanced manufacturing capabilities and a robust research and development pipeline, the organization addresses complex medical needs across international markets, prioritizing the delivery of high-quality, innovative therapies.

Recent filings

Filing Released Lang Actions
Transcript of the post results earnings call held on May 19, 2026
Call Transcript Classification · 98% confidence The document is labeled as the “Transcript of the post results earnings call” and contains the full text of the Q4 FY26 conference call including management remarks and Q&A format. It is not merely an announcement or link to a report but the actual earnings call transcript. This matches the definition for Call Transcript (Code: CT).
2026-05-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 98% confidence The document is the full transcript of Zydus Lifesciences’ Q4 FY26 post-results earnings call held on May 19, 2026, including management remarks and Q&A. This matches the definition of a Call Transcript.
2026-05-24 English
The Company is going to participate in Bank of America India Conference at Mumbai on June 2, 2026.
Regulatory Filings Classification · 70% confidence The document is a short notice to the stock exchanges informing them of the company’s participation in an upcoming investor conference. It contains no financial results, presentation materials, or voting information—just a general regulatory announcement. It does not constitute an investor presentation itself, a management discussion, an earnings release, or any other specific report. Therefore, it falls into the fallback category for miscellaneous regulatory announcements (RNS).
2026-05-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a brief notice to stock exchanges notifying participation in an investor conference. It does not present financial results, regulatory forms, voting results, or any other specific reporting content. It is an announcement of an event, not a detailed report, making it a general regulatory announcement. It therefore falls under the fallback category Regulatory Filings (RNS).
2026-05-23 English
Updates
Transaction in Own Shares Classification · 98% confidence The document is a formal public announcement under SEBI Buy-Back Regulations regarding the company’s proposal and process to repurchase (buy back) its own equity shares. This is a transaction in its own shares, not a dividend, financing update, or management change. Therefore, the correct classification is POS (Transaction in Own Shares).
2026-05-21 English
Public Announcement
Transaction in Own Shares Classification · 88% confidence The document is a detailed Public Announcement under SEBI Buyback Regulations by Zydus Lifesciences Limited regarding the share buyback of up to 95,65,217 equity shares at a specified price, filed with BSE and NSE. This is not a fundraising but a share repurchase. According to the filing definitions, a company’s announcement of its own share buyback falls under “Transaction in Own Shares” (POS).
2026-05-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.